Alerts

About Octagam 5%: lifting of the voluntary recall

We are advising that Movectro (cladribine) has been withdrawn from supply in Australia due to commercial reasons.

We are reviewing the safety of the Pneumovax 23 vaccine due to reports of severe local reactions and have updated our revaccination recommendations.

On 26 January 2011, the US Food and Drug Administration (FDA) announced a safety communication to warn about an association between breast implants and anaplastic large cell lymphoma. The risk of a patient developing this type of lymphoma is very low.

We are recalling Thelin (sitaxentan) worldwide due to serious liver risks. Consult your doctor if you have concerns.

Seasonal flu vaccine: Response to the West Australian (Stokes) Review

Do not use So Hard for Men tablets, Shaguar tablets, and Pulse8 for Women capsules as they contain undeclared tadalafil and are not approved. Consult your doctor if you have concerns.

Weight loss drug Sibutramine (Reductil) withdrawn in Australia due to heart risks.

The TGA is aware that the French authorities have now released an updated statement in regard to the testing of the PIP implants: